Identification of a Gene Panel Predictive of Triple-Negative Breast Cancer Response to Neoadjuvant Chemotherapy Employing Transcriptomic and Functional Validation

Triple-negative breast cancer (TNBC) patients exhibiting pathological complete response (pCR) have better clinical outcomes compared to those with residual disease (RD). Therefore, robust biomarkers that can predict pCR may help with triage and resource prioritization in patients with TNBC. Herein,...

Descripción completa

Detalles Bibliográficos
Autores principales: Vishnubalaji, Radhakrishnan, Abdel-Razeq, Hikmat, Gehani, Salahddin, Albagha, Omar M. E., Alajez, Nehad M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506546/
https://www.ncbi.nlm.nih.gov/pubmed/36142814
http://dx.doi.org/10.3390/ijms231810901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506546/
https://www.ncbi.nlm.nih.gov/pubmed/36142814
http://dx.doi.org/10.3390/ijms231810901

Ejemplares similares